Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-24 @ 11:08 PM
NCT ID: NCT03485469
Eligibility Criteria: Inclusion criteria: * Obese patient (BMI = 30 kg / m ²) * 18 - 65 years ( inclusive borders) * Patient in failure of bariatric surgery and in which no surgical resumption can be proposed (in view of Reinhold's classification, the failure will be considered as a loss of overweight lower than 50 % in two years further to a bariatric surgery). * Informed consent * Patient in measure to realize all the visits and to follow the procedures of the study - Subject affiliated to a social security system Exclusion criteria: * Pregnancy current or planned during the duration of the study, pregnant or breast-feeding women * Craniopharyngioma or any other evolutionary malignant pathology, or chronic illness in decompensation phase * Strong probability of not compliance to the protocol or drop-out * Psychiatric pathology of dissociated type (schizophrenia; psychosis, bipolarity …) * Sensory (hearing, visual) or cognitive deficits susceptible to hinder the progress of the sessions. * Incapacity to understand the nature and the purpose of the study and\\or communication difficulties with the investigator * Patient having already benefited from a coverage by hypnotherapy for loss of weight * Taken by treatment having an impact on the loss of weight (corticoid, antithyroid …) * Major protected by the law or considered vulnerable (under guardianship)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT03485469
Study Brief:
Protocol Section: NCT03485469